ストックスクリーナーアプリを入手
101.29
0.22%
0.22
アフターアワーズ：
100.96
-0.33
-0.33%
Abbott Laboratories (ABT) 最新ニュース
Gilead vs. Abbott: Which Dividend Healthcare Stock Offers the Better Risk-Reward? - Yahoo Finance
3 Dividend Stocks To Watch As High Rates Test Defensive Shares - simplywall.st
Form 4 Abbott Laboratories For: 25 September By Investing.com - Investing.com India
At $103.99 a share, an Abbott Laboratories (ABT) director delivered or withheld shares for exercise costs or taxes. - Stock Titan
Abbott Laboratories stock falls 2.32 percent below yearly high effects? no - AD HOC NEWS
Is Abbott Laboratories (NYSE:ABT) Facing a Real Market Test? - Kalkine Media
Abbott Laboratories stock loses 1.82 percent before the bell - ad-hoc-news.de
How Lingo Partnership Will Impact Abbott Stock (ABT) - simplywall.st
Abbott to pay nearly $385 million to settle infant formula allegations - ConsumerAffairs
Abbott Laboratories (ABT) is Facing Segment Competition and Sluggish Nutrition Recovery - Yahoo Finance
Abbott Laboratories stock reports Q2 growth and earnings beat - AD HOC NEWS
Mexico Cardiac Rhythm Management Devices Market Outlook to 2036 Provides Revenue, Volume, Pricing and Competitive Insig - GlobeNewswire Inc.
Abbott Laboratories stock rises 0.69 percent ahead of the open - AD HOC NEWS
Abbott partners with Berry Street to add nutrition coaching to Lingo - Drug Delivery Business
Abbott Laboratories stock ends the day 0.69 percent higher at USD 103.69 - AD HOC NEWS
Abbott Laboratories: A Strong Business At A Fair Price (NYSE:ABT) - Seeking Alpha
Sinocare Asks Court To Rule Device Won't Infringe Abbott IP - Law360
What Makes Abbott Laboratories (ABT) an Attractive Opportunity? - Yahoo Finance
Abbott and Berry Street team up on personalized nutrition tracking - marketscreener.com
Is Abbott Laboratories (ABT) Still Undervalued On Volt’s First US And Canada Procedures? - simplywall.st
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Abbott and Berry Street partner to combine gluc... - Pluang
A 15% discount on Abbott's four-week glucose-monitor plans will go to Berry Street users. - Stock Titan
Abbott Laboratories stock gains 1.12 percent as settlement weighs - AD HOC NEWS
US companies face rise in cyber attacks - Reuters
Abbott Laboratories stock heads into the open after a 1.12 percent gain - AD HOC NEWS
The Premium On Abbott Laboratories Keeps Growing. So Does The Case For Stryker and Boston Scientific - Trefis
Calls to sign infant formula testing bill into law in New York - Spectrum News
Abbott Laboratories stock ends the day 1.12 percent higher - AD HOC NEWS
Abbott to pay almost $385M in DOJ settlement over infant formula plant allegations - Compliance Week
Abbott: Quality Remains, But Exact Sciences Has Raised The Bar For Buy (NYSE:ABT) - Seeking Alpha
Sibionics Challenges Abbott Patent In Glucose Monitor Fight - Law360
3 Health Care Stocks With Whale Alerts In Today’s Session - benzinga.com
Abbott Laboratories stock gains 0.36 percent as revenue reaches USD 12.6 billion - AD HOC NEWS
Abbott Laboratories stock heads into the open after a 0.7 percent gain - AD HOC NEWS
Abbott vs. Intuitive Surgical: Two Healthcare Titans on Diverging Growth Curves - NAI500
Abbott Laboratories Agencies, 2018 - OpenSecrets
NC gets $216K from Abbott baby formula settlement - WSOC TV
NC reaches settlement with Abbott over contaminated baby formula that led to 2022 shortage - WRAL
Abbott Laboratories stock ends the day modestly higher at the close - AD HOC NEWS
Abbott Laboratories Lobbyists, 2022 - OpenSecrets
Abbott Laboratories Agencies, 2012 - OpenSecrets
Abbott Laboratories vs. Intuitive Surgical: Recent Quarterly Revenue Trends Reveal a Classic Investing Truth - The Motley Fool
Abbott Laboratories To Pay $385M Over Allegations Of Tainted Infant Formula - Patch
Abbott Laboratories Agencies, 2002 - OpenSecrets
Abbott Laboratories stock slips 2.0 percent after Friday close - AD HOC NEWS
Abbott Laboratories Agrees to Pay Over $384 Million to Settle Allegations Related to Contaminated Infant Formula - Sierra Sun Times
Abbott Laboratories stock heads into the open after a 2.0 percent drop. - AD HOC NEWS
Wheels Up for Oslo, With One New Slide: Abbott Paid $385 Million, and Nobody Was Charged - Marler Blog
Abbott Laboratories stock holds near USD 102 after July results - AD HOC NEWS
Why Is the Market Reassessing Abbott Laboratories (ABT)? - Kalkine Media
Abbott Laboratories Agencies, 2019 - OpenSecrets
Abbott Laboratories Lobbyists, 2018 - OpenSecrets
3 Dividend Stocks to Buy and Hold for 10 Years - The Globe and Mail
Abbott's Spine Implants Cause Nerve Damage, Suit Claims - law360.com
Abbott Laboratories to pay $384 million over infant formula contamination risk claims - myvalleynews.com
NYS to receive $9.3 million in Abbott Laboratories baby formula settlement - WGRZ
Abbott Laboratories Stock (ABT) Opinions on Infant Formula Settlement - Quiver Quantitative
Casa Grande baby formula plant tied to $384m settlement over unsafe production - AZPM News
Attorney General James Secures Over $9 Million for New York from Abbott Laboratories for Manufacturing Potentially Unsafe Baby Formula - The Indian Panorama
Why Wall Street Is Becoming Even More Bullish About This Dividend King - The Motley Fool
Abbott settles safety standards federal suit that started in Sturgis - Sturgis Journal
Abbott to pay $385 million over Michigan baby formula recall that fueled 2022 shortage - Yahoo Finance
Abbott Labs to pay $384M over contaminated infant formula allegations - NewsNation
0.15%
1.70%
大文字化:
|
ボリューム (24 時間):